Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension
Hypertension

About this trial
This is an interventional treatment trial for Hypertension focused on measuring High normal blood pressure, Stage I
Eligibility Criteria
Inclusion Criteria:
- High normal blood pressure (130/85 - 139/89) or stage I hypertension (140/90 - 150/90)
- Ability to follow simple instructions
Exclusion Criteria:
- Age below 60 years.
- Individuals living in long term care homes.
- Individuals unable to walk for 30 minutes.
- Unstable diabetes, or diabetics taking insulin (note: eligible diabetic participants will undergo additional testing during the study ).
- Current cancer or diagnosed with cancer in the past 2 years.
- Significant liver or other gastrointestinal disorder including inflammatory bowel disease. (While constipation is the most common gastrointestinal problem in the elderly, it would not be a contraindication)
- Significant kidney disorder.
- Have taken oral antibiotics in the past three months
- Unstable or severe cardiac disease, recent myocardial infarction, or stroke (either in past 6 months or significantly affecting physical mobility).
- Unstable other medical disease including, but not limited to, pulmonary disorder, epilepsy and genitourinary disorder.
- Migraine with aura within the last year (as this is a risk factor for stroke).
- Current diagnosis of a bleeding condition, or at risk of bleeding.
- Significant immune-compromise.
- Current use of hormone replacement therapy (except thyroid).
- Current use of blood pressure medications and/or diuretics
- Current use of flax seed supplement
- Participation in any other clinical trial with an investigational agent within one month prior to randomization.
Sites / Locations
- College of Pharmacy, University of Saskatchewan
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Placebo Comparator
Experimental
Sham Comparator
BeneFlax® + walking training (Dash)
Placebo + walking training (Dash)
BeneFlax® + flexibility training (Dash)
Placebo + flexibility training (Dash)
BeneFlax (0.8 g, twice a day) with exercise training (30-60 minutes walking training, 5 times a week) for 8 weeks; all participants encouraged to follow Dash Eating Plan.
Placebo (whey powder isocaloric to BeneFlax) with exercise training (30-60 minutes walking training, 5 times a week) for 8 weeks; all participants encouraged to follow Dash Eating Plan.
BeneFlax (0.8 g, twice a day) with placebo exercise training (flexibility training, 5 times a week) for 8 weeks; all participants encouraged to follow Dash Eating Plan.
Placebo (whey powder isocaloric to BeneFlax) with placebo exercise training (flexibility training, 5 times a week) for 8 weeks; all participants encouraged to follow Dash Eating Plan.